Prostate Cancer - Results from #20700

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localized prostate cancer using WST11-Vascular Targeted Photodynamic (VTP) therapy - Abstract July 1, 2014

Risk of second primary tumors in men diagnosed with prostate cancer: A population-based cohort study - Abstract July 1, 2014

Shear wave elastography for detection of prostate cancer: A preliminary study - Abstract July 1, 2014

11C-Choline PET/CT in the primary diagnosis of prostate cancer: Impact on treatment planning - Abstract July 1, 2014

Implications of the new AUA guidelines on prostate cancer detection in the U.S. - Abstract July 1, 2014

Prostate cancer vaccines in combination with additional treatment modalities - Abstract June 30, 2014

High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer: Are high-risk patients good candidates? - Abstract June 30, 2014

Metabolomics approaches and applications in prostate cancer research - Abstract June 30, 2014

National survey addressing the information needs of primary care physicians: Side effect management of patients on androgen deprivation therapy - Abstract June 30, 2014

Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) - Abstract June 30, 2014

Multiparametric MRI in prostate cancer management - Abstract June 30, 2014

High-risk prostate cancer-classification and therapy - Abstract June 30, 2014

Predictive postoperative model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy as monotherapy - Abstract June 30, 2014

Association of reimbursement policy and urologists׳ characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer - Abstract June 30, 2014

Future of bisphosphonates and denosumab for men with advanced prostate cancer - Abstract June 28, 2014

Cabazitaxel remains active in patients progressing after docetaxel followed by novel androgen receptor pathway targeted therapies - Abstract June 28, 2014

Comparative study of histological results between transuretral resection and biopsy cores of the prostate - Abstract June 28, 2014

Will active surveillance for clinically localized prostate cancer survive in the era of individualized medicine? - Abstract June 28, 2014

Hypnotic relaxation therapy for treatment of hot flashes following prostate cancer surgery: A case study - Abstract June 28, 2014

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling - Abstract June 28, 2014

Page 1036 of 1457